Peanut allergy vaccine (Allertein Therapeutics)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePeanut allergy vaccine (Allertein Therapeutics)
Drug Alias NameE. Coli-Encapsulated-Recombinant Modified Peanut Proteins Ara h 1/Ara h 2 and Ara h 3, ,,EMP-123
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPeanut HypersensitivityFood HypersensitivityHypersensitivity, Immediate +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllertein
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllertein Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsPeanut HypersensitivityFood HypersensitivityHypersensitivity, Immediate +[4] 

Other Information

ATC CodeN/A
Related LinksN/A